Sera Prognostics (NASDAQ:SERA – Get Rating) is one of 45 publicly-traded companies in the “Medical laboratories” industry, but how does it contrast to its rivals? We will compare Sera Prognostics to similar companies based on the strength of its analyst recommendations, valuation, profitability, risk, earnings, dividends and institutional ownership. Analyst Ratings This is a breakdown […]